Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ScanSource Reiterated FY25 Revenues Of $3.1B-$3.5B Vs. $3.31B Estimate And Free Cash Flow (Non-GAAP) Of At least $70M

Author: Benzinga Newsdesk | November 07, 2024 08:34am

Annual Financial Outlook for Fiscal Year 2025

ScanSource reaffirms previously provided guidance set forth below for the full fiscal year ended June 30, 2025.

  FY25 Annual Outlook 
Net sales $3.1 billion to $3.5 billion 
Adjusted EBITDA (non-GAAP) $140 million to $160 million 
Free cash flow (non-GAAP) At least $70 million 

Posted In: SCSC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist